Small Cell Lung Cancer Extensive Stage Clinical Trials in Chengdu, Sichuan
2 recruitingChengdu, Sichuan, China
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
Small Cell Lung Cancer Extensive Stage
Merck Sharp & Dohme LLC170 enrolled31 locationsNCT07227597
Recruiting
Phase 1
Phase I Clinical Study of α-PD-L1/DLL3 CAR-T in Patients With R/R SCLC
Small Cell Lung Cancer Extensive Stage
Sichuan University28 enrolled1 locationNCT06348797